Superiority of Mature Differentiated Cultured Human Corneal Endothelial Cell Injection Therapy for Corneal Endothelial Failure

眼科 细胞 细胞疗法 单元格排序 角膜内皮 医学 内皮干细胞 不利影响 视力 男科 角膜 外科 化学 体外 药理学 生物化学
作者
Morio Ueno,Munetoyo Toda,Kohsaku Numa,Hiroshi Tanaka,Kojiro Imai,John Bush,Satoshi Teramukai,Naoki Okumura,Noriko Koizumi,Akihisa Yamamoto,Motomu Tanaka,Chie Sotozono,Junji Hamuro,Shigeru Kinoshita
出处
期刊:American Journal of Ophthalmology [Elsevier BV]
卷期号:237: 267-277 被引量:28
标识
DOI:10.1016/j.ajo.2021.11.012
摘要

PURPOSETo investigate the safety and efficacy of cultured human corneal endothelial cell (hCEC) injection therapy with mature differentiated (mature) cell subpopulations (SPs) for corneal endothelial failure (CEF).DESIGNComparative, interventional case series.METHODSThis study involved 18 eyes with CEF that underwent cultured hCEC injection therapy, categorized into 2 groups: (1) 11 eyes administered a relatively lower proportion (0.1 to 76.3%) of mature cell SPs (group 1 [Gr1]), and (2) 7 eyes administered a relatively higher proportion (>90%) of mature cell SPs (group 2 [Gr2]). From 1 week to 3 years postoperation, corneal endothelial cell (CEC) density (CECD), central corneal thickness (CCT), and best-corrected visual acuity (BCVA) were recorded, and the CEC parameter's "spring constant" was calculated. The proportion of mature SPs was evaluated by fluorescence-activated cell sorting analysis based on cell-surface markers.RESULTSAt 3 years postoperation, corneal restoration with improved BCVA was attained in 10 of the 11 Gr1 eyes and all Gr2 eyes, the median CECD in Gr2 (3083 cells/mm2; range, 2182-4417 cells/mm2) was higher than that in Gr1 (1349 cells/mm2; range, 746-2104 cells/mm2) (P < .001), and the spring constant verified the superiority of the mature cultured hCECs. From 24 weeks through 3 years postoperation, the median percentage of CECD decrease was 3.2% in Gr2 and 23.6% in Gr1 (P < .005). CCT recovery was prompt and constant in Gr2, while diverse in Gr1. No adverse events were observed.CONCLUSIONOur findings showed that mature cell SPs for hCEC injection therapy provide rapid recovery of CCT, better CECD, and low CECD attrition over 3 years postsurgery. To investigate the safety and efficacy of cultured human corneal endothelial cell (hCEC) injection therapy with mature differentiated (mature) cell subpopulations (SPs) for corneal endothelial failure (CEF). Comparative, interventional case series. This study involved 18 eyes with CEF that underwent cultured hCEC injection therapy, categorized into 2 groups: (1) 11 eyes administered a relatively lower proportion (0.1 to 76.3%) of mature cell SPs (group 1 [Gr1]), and (2) 7 eyes administered a relatively higher proportion (>90%) of mature cell SPs (group 2 [Gr2]). From 1 week to 3 years postoperation, corneal endothelial cell (CEC) density (CECD), central corneal thickness (CCT), and best-corrected visual acuity (BCVA) were recorded, and the CEC parameter's "spring constant" was calculated. The proportion of mature SPs was evaluated by fluorescence-activated cell sorting analysis based on cell-surface markers. At 3 years postoperation, corneal restoration with improved BCVA was attained in 10 of the 11 Gr1 eyes and all Gr2 eyes, the median CECD in Gr2 (3083 cells/mm2; range, 2182-4417 cells/mm2) was higher than that in Gr1 (1349 cells/mm2; range, 746-2104 cells/mm2) (P < .001), and the spring constant verified the superiority of the mature cultured hCECs. From 24 weeks through 3 years postoperation, the median percentage of CECD decrease was 3.2% in Gr2 and 23.6% in Gr1 (P < .005). CCT recovery was prompt and constant in Gr2, while diverse in Gr1. No adverse events were observed. Our findings showed that mature cell SPs for hCEC injection therapy provide rapid recovery of CCT, better CECD, and low CECD attrition over 3 years postsurgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
万能图书馆应助zz123采纳,获得10
刚刚
杜康完成签到,获得积分10
刚刚
Cheung2121发布了新的文献求助10
刚刚
医学小王完成签到 ,获得积分10
1秒前
3秒前
刘涵完成签到 ,获得积分10
4秒前
帅气的沧海完成签到 ,获得积分10
5秒前
辣辣辣辣辣辣完成签到 ,获得积分10
8秒前
9秒前
12秒前
乐观半兰完成签到,获得积分10
14秒前
14秒前
小丸子和zz完成签到 ,获得积分10
15秒前
量子星尘发布了新的文献求助10
16秒前
江雁完成签到,获得积分10
16秒前
坚定芯完成签到,获得积分10
16秒前
叶子兮完成签到,获得积分10
18秒前
幽默的妍完成签到 ,获得积分10
18秒前
Snow完成签到 ,获得积分10
18秒前
18秒前
liuyuh完成签到,获得积分10
19秒前
悠明夜月完成签到 ,获得积分10
20秒前
乌云乌云快走开完成签到,获得积分10
20秒前
你是我的唯一完成签到 ,获得积分10
20秒前
洁白的故人完成签到 ,获得积分10
22秒前
乐观半兰发布了新的文献求助10
22秒前
water应助科研通管家采纳,获得10
23秒前
zhang完成签到 ,获得积分10
23秒前
water应助科研通管家采纳,获得10
23秒前
Jasper应助科研通管家采纳,获得10
23秒前
科研通AI2S应助科研通管家采纳,获得10
23秒前
orixero应助科研通管家采纳,获得10
23秒前
CodeCraft应助科研通管家采纳,获得10
23秒前
大模型应助科研通管家采纳,获得10
23秒前
23秒前
鲲鹏完成签到 ,获得积分10
24秒前
大气建辉完成签到 ,获得积分10
24秒前
尛森完成签到,获得积分10
24秒前
机灵枕头完成签到 ,获得积分10
25秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022